I don’t think there would be this sort of dilution - 50 million shares. No . Way too high .
Even if there were, fully diluted - my guesstimate , is it could only be by issuing of options , still, eg. to key stakeholders .
Who will hold them, or Hold the shares .
The management team , these men are the people doing the seriously , intense and high experience required work here with Bisantrene of course . They are not going to risk all their work or have it taken too cheaply.
Key management notably : Hold onto their - Options / or the Shares .
To protect their investment, not for selfish reasons as in to hold and not sell into the market , accumulation - but seriously because they are key stakeholders and this management , they are Serious. Final market capitalisation is what matters and theirs and everyones share of this .
* They protect all shareholders and the shareprice - which is market cap. also .
Issuing more shares - dilutes this .
And - more importantly :
These men , knew and calculated from the outset that they could Hold their positions , through all the journey and whatever work will be done .
This was very important- to them , to maximise and insure their own work and return on sweat to be worth it beyond the worthwhile task of bringing back Bisantrene or other worthy drugs , but for their own reputation and the personal huge work and investment, that this is worthwhile and has integrity , important to do .
With all the compromises and sacrifices required from their own lives - they are backing themselves and have everyone’s backs including their own !
By rigidly holding out as much as possible against dilution they also earn more value for their work and the company in the end . For sure .
And NO Lowball manipulation or loss of control as time goes by .
I am very grateful to them .
The management teams Holding alone is above the key 35-40 % level - prevents suppression and pressure on the shareprice.
In short -
Mainly I have huge , serious, respect for and am in awe of , this management team; and am very keen for this drug prospect to be brought into the clinics and market and available for a broad number of very dire and acute cancers , hopefully including breast & ovarian cancers.
I am thankful for the calibre and very high qualifications and expertise of this management team .
And for their capacity to do this - bring back Bisantrene.
Responsibilities of the team, page-94
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.55 |
Change
-0.020(1.27%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.51 | $218.3K | 138.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 95 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29100 | 1.500 |
1 | 353 | 1.470 |
2 | 3444 | 1.440 |
3 | 101000 | 1.420 |
4 | 14785 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 157 | 1 |
1.580 | 6715 | 2 |
1.600 | 2319 | 1 |
1.620 | 5327 | 1 |
1.630 | 1270 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |